Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.120
+0.020 (0.49%)
Jun 26, 2026, 3:06 PM EDT - Market open
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $408.61 million as of June 26, 2026. Its market cap has increased by 391.05% in one year.
Market Cap
408.61M
Enterprise Value
339.32M
1-Year Change
391.05%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $408.61M, a decrease of -49.34%. That is a compound annual growth rate of -11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 408.61M | 71.00% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 445.27M |
| Forte Biosciences | 443.51M |
| Benitec Biopharma | 442.48M |
| Autolus Therapeutics | 441.80M |
| vTv Therapeutics | 438.37M |
| Sagimet Biosciences | 435.97M |
| Century Therapeutics | 434.66M |
| Ovid Therapeutics | 433.01M |